Intraoperative neurophysiological monitoring and survival outcomes in patients with IDH–wildtype glioblastoma

Clicks: 7
ID: 334154
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #63 of 65 articles by views in Neuro-Oncology Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Intraoperative neurophysiological monitoring (IONM) facilitates safe glioma resection in eloquent regions. Its effect on survival in molecularly defined IDH–wildtype glioblastoma remains uncertain. We assessed the association between IONM-supported surgery and survival outcomes in this high-risk population and explored subgroups deriving the greatest benefit. Methods We retrospectively analyzed 200 adults who underwent first-time resection for IDH–wildtype glioblastoma between 2012 and 2021. Co-primary outcomes were progression-free survival (PFS) and overall survival (OS), evaluated through Kaplan–Meier estimates and multivariable Cox models. Secondary 1:1 propensity score-matched analyses were performed based on age, preoperative KPS, MGMT methylation status, preoperative tumor volumes and localization. Volumetric analysis included contrast-enhancing (CE) and non–CE tumor components. Subgroup analyses were stratified by tumor location. Results In the unmatched cohort, IONM was independently associated with prolonged PFS (HR 0.60, 95% CI 0.45–0.84) and OS (HR 0.60, 95% CI 0.43–0.83), along with younger age, MGMT methylation, higher KPS, and smaller postoperative volumes. IONM patients had higher complete CE resection rates (64.2% vs 40.4%, P = 0.0005) and improved functional preservation (postoperative KPS 80 vs. 70, P = 0.008), despite more early deficits. In the location-matched cohort (n = 104), median PFS was 12 months with IONM vs 7 months without (P = 0.0007), and OS was 17 vs 11 months (P = 0.0018). Supramaximal resections occurred exclusively in the IONM group. The benefit was most evident in frontal, parietal, and insular tumors. Conclusions IONM-supported surgery was associated with more extensive resection, functional preservation, and longer survival in IDH–wildtype glioblastoma. IONM was more frequently used in tumors located in frontal, parietal, and insular regions, consistent with the functional complexity of these areas.
Reference Key
openalex_W7223709026 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Giorgio Fiore, Giulio Bertani, Giorgio Giovanni Carrabba, Mauro Pluderi, Stefano Borsa, Giorgio Conte, Maurizio Vergari, Stefania Elena Navone, Laura Guarnaccia, Filippo Maria Cogiamanian, Giovanni Marfia, Manuela Caroli, Marco Locatelli
Are you one of these authors? Claim your profile
Journal Neuro-Oncology Practice
Year 2026
DOI
10.1093/nop/npag109
URL
https://doi.org/10.1093/nop/npag109
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.